AAAAAA

   
Results: 1-8 |
Results: 8
Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae
Authors: Pozio, E Sacchini, D Sacchi, L Tamburrini, A Alberici, F
Citation: E. Pozio et al., Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae, CLIN INF D, 32(4), 2001, pp. 638-642
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study
Authors: Lepri, AC Phillips, AN Monforte, AD Castelli, F Antinori, A de Luca, A Pezzotti, P Alberici, F Cargnel, A Grima, P Piscopo, R Prestileo, T Scalise, G Vigevani, M Moroni, M
Citation: Ac. Lepri et al., When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study, AIDS, 15(8), 2001, pp. 983-990
Antiretroviral therapy in HIV-infected individuals in clinical practice: Are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?
Authors: Pezzotti, P Monforte, AD Bugarini, R Rezza, G Arici, C Angarano, G Borderi, M Alberici, F Armignacco, O Menichetti, F Prestileo, T Sighinolfi, L Sinicco, A Resta, F Vigevani, M Ippolito, G
Citation: P. Pezzotti et al., Antiretroviral therapy in HIV-infected individuals in clinical practice: Are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?, EUR J EPID, 16(10), 2000, pp. 919-926
Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies
Authors: Alberici, F Pagani, L Ratti, G Viale, P
Citation: F. Alberici et al., Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies, BR J DERM, 142(5), 2000, pp. 969-972
Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment
Authors: Dorrucci, M Balducci, M Pezzotti, P Sinicco, A Alberici, F Rezza, G
Citation: M. Dorrucci et al., Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: Estimates of the population effect of treatment, J ACQ IMM D, 22(1), 1999, pp. 65-70
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease
Authors: Floridia, M Bucciardini, R Ricciardulli, D Fragola, V Pirillo, MF Weimer, LE Tomino, C Giannini, G Galluzzo, CM Andreotti, M Cargnel, A Alberici, F De Rienzo, B Leoncini, F Fiaccadori, F Francisci, D Grillone, W Ortona, T Piazza, S Scalzini, A Nigra, E Tumietto, F Vella, S
Citation: M. Floridia et al., A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease, J ACQ IMM D, 20(1), 1999, pp. 11-19
Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters
Authors: Lori, F Rosenberg, E Lieberman, J Foli, A Maserati, R Seminari, E Alberici, F Walker, B Lisziewicz, J
Citation: F. Lori et al., Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters, AIDS RES H, 15(15), 1999, pp. 1333-1338
Longitudinal human immunodeficiency virus type 1 load in the Italian seroconversion study: Correlates and temporal trends of virus load
Authors: Lyles, CM Dorrucci, M Vlahov, D Pezzotti, P Angarano, G Sinicco, A Alberici, F Alcorn, TM Vella, S Rezza, G
Citation: Cm. Lyles et al., Longitudinal human immunodeficiency virus type 1 load in the Italian seroconversion study: Correlates and temporal trends of virus load, J INFEC DIS, 180(4), 1999, pp. 1018-1024
Risultati: 1-8 |